ストックスクリーナーアプリを入手
1.17
4.46%
0.05
前日終値:
$1.12
開ける：
$1.14
24時間の取引高:
90,545
Relative Volume:
0.53
時価総額：
$26.19M
収益：
-
当期純損益:
$-61.06M
株価収益率:
-0.0817
EPS:
-14.3261
ネットキャッシュフロー:
$-59.30M
1週間 パフォーマンス:
-0.85%
1か月 パフォーマンス:
-1.68%
6か月 パフォーマンス:
-47.77%
1年 パフォーマンス:
-60.47%
1日の値動き範囲:
$1.14
$1.185
1週間の範囲:
$1.0501
$1.185
52週間の値動き範囲:
$1.00
$4.72
Boundless Bio Inc Stock (BOLD) Company Profile
BOLD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
1.17 | 25.07M | 0 | -61.06M | -59.30M | -14.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-05-28 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-12-13 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-04-22 | 開始されました | Guggenheim | Buy |
| 2024-04-22 | 開始されました | Leerink Partners | Outperform |
| 2024-04-22 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Boundless Bio Inc (BOLD) 最新ニュース
Using portfolio simulators with Boundless Bio Inc. included2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Has Boundless Bio Inc. formed a bullish divergenceJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - Newser
Is it too late to sell Boundless Bio Inc.Weekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
Is Boundless Bio Inc. reversing from oversold territoryTrend Reversal & Free Reliable Trade Execution Plans - Newser
Leading vs lagging indicators on Boundless Bio Inc. performanceInsider Selling & Technical Entry and Exit Tips - Newser
Using Ichimoku Cloud for Boundless Bio Inc. technicals2025 Market WrapUp & Low Drawdown Investment Ideas - Newser
What’s next for Boundless Bio Inc. stock priceJuly 2025 Highlights & Low Risk Investment Opportunities - Newser
Momentum divergence signals in Boundless Bio Inc. chart [July 2025 Opening Moves]Precise Swing Trade Entry Alerts - Newser
Best data tools to analyze Boundless Bio Inc. stock [Market Trend Review]Weekly Top Performers Watchlists - Newser
Statistical indicators supporting Boundless Bio Inc.’s strengthAI Trend Detection for Entry Timing - Newser
What makes Boundless Bio Inc. stock price move sharplyEarly Entry Planner for Swing Candidates - Newser
Why Boundless Bio Inc. stock attracts strong analyst attentionBreakout Stocks with Huge Upside - thegnnews.com
How Boundless Bio Inc. stock performs during market volatilityFree Risk Adjusted Technical Entry Plan - Newser
Forecasting Boundless Bio Inc. price range with options dataSector Rotation and Stock Opportunity Analysis - Newser
Boundless Bio stock price target lowered to $4 at H.C. Wainwright - Investing.com Australia
Boundless Bio: HC Wainwright Maintains Buy Rating, Lowers PT to $4 - AInvest
Will Boundless Bio Inc. rebound enough to break evenFree Growth Based Investment Plan Guidance - Newser
Can Boundless Bio Inc. expand into new marketsHigh Confidence Setup Screener - thegnnews.com
Boundless Bio Inc. stock volume spike explainedBuy Strategy Tracker with Growth Indicators - Newser
Signal strength of Boundless Bio Inc. stock in tech scannersFree Short Term Setup With Predictive Chart - Newser
Real time breakdown of Boundless Bio Inc. stock performanceFree Secure Capital Picks With Upside Potential - Newser
Published on: 2025-08-05 20:14:30 - Newser
Boundless Bio Q2 R&D Expenses Down 17%, Cash to Fund Operations Until H1 2028 - AInvest
Boundless Bio (BOLD) Q2 R&D Drops 17% - Nasdaq
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Boundless Bio's Strategic Focus on ecDNA-Driven Oncology and Extended Runway: A Biotech Investment for the Long Term - AInvest
What earnings revisions data tells us about Boundless Bio Inc.Free Smart Trend Trading with Weekly Signals - Newser
Is Boundless Bio Inc. stock poised for growthTechnical Screener for High Growth Stocks - Newser
What are the technical indicators suggesting about Boundless Bio Inc.Discover investment plans that deliver results - Jammu Links News
Is a relief rally coming for Boundless Bio Inc. holdersChart Pattern Recognition for Profit Timing - Newser
When is Boundless Bio Inc. stock expected to show significant growthInvest confidently with daily market forecasts - Jammu Links News
What are Boundless Bio Inc. company’s key revenue driversFree Predictions - Jammu Links News
Is Boundless Bio Inc. stock overvalued or undervaluedAccess high-quality stock research instantly - Jammu Links News
What analysts say about Boundless Bio Inc. stockMassive portfolio appreciation - Jammu Links News
Boundless Bio Inc (BOLD) 財務データ
収益
当期純利益
現金流量
EPS
1.67%
大文字化:
|
ボリューム (24 時間):